Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,106 public trials 617 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)

NCT00079482

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Mayo-Scottsdale Scottsdale, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • USC/Norris Cancer Center Los Angeles, California, United States
View all 81 locations
View Trial Details
Completed

Topotecan in Treating Patients With Myelodysplastic Syndrome

NCT00003675

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +14 more
Locations
  • Veterans Affairs Medical Center - Birmingham Birmingham, Alabama, United States
  • University of California San Diego Cancer Center La Jolla, California, United States
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • Veterans Affairs Medical Center - San Francisco San Francisco, California, United States
View all 48 locations
View Trial Details
Completed

Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT00006265

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • Veterans Affairs Medical Center - Birmingham Birmingham, Alabama, United States
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Veterans Affairs Medical Center - San Diego San Diego, California, United States
View all 78 locations
View Trial Details
Completed

Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2

NCT00896701

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hematologic Diseases, +6 more
Locations
  • Kinston Medical Specialists Kinston, North Carolina, United States
  • Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details

Related conditions